Côd QR

Early costs and complications of first-line low-grade glioma treatment using a large national database: Limitations and future perspectives

IntroductionDiffuse Low-grade gliomas (DLGG, WHO Grade II) are a heterogenous group of tumors comprising 13–16% of glial tumors. While maximal safe resection is endorsed as the best approach to DLGG, compared to more conservative interventions like stereotactic biopsy, the added costs and risks have...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Kyle Tuohy, Djibril M. Ba, Debarati Bhanja, Douglas Leslie, Guodong Liu, Alireza Mansouri
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2023-02-01
Cyfres:Frontiers in Surgery
Pynciau:
low-grade glioma (WHO grade II)
cost
resection
stereotactic biopsy
adverse events—complications
MarketScan database
Mynediad Ar-lein:https://www.frontiersin.org/articles/10.3389/fsurg.2023.1001741/full
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg